BRISTOL-MYERS SQUIBB COMPANY and THE BANK OF NEW YORK MELLON, as Trustee THIRTEENTH SUPPLEMENTAL INDENTURE Dated as of March 2, 2022 to INDENTURE Dated as of June 1, 1993 $1,750,000,000 2.950% Notes due 2032 $1,250,000,000 3.550% Notes due 2042...Indenture • March 2nd, 2022 • Bristol Myers Squibb Co • Pharmaceutical preparations • New York
THIRTEENTH SUPPLEMENTAL INDENTURE, dated as of March 2, 2022 (the “Thirteenth Supplemental Indenture”), between Bristol-Myers Squibb Company, a corporation duly organized and existing under the laws of the State of Delaware, having its principal office at 430 East 29th Street, New York, New York 10016 (the “Company”), and The Bank of New York Mellon, a New York banking corporation (successor to The Chase Manhattan Bank (National Association)), as trustee (the “Trustee”).
